AI Agents for Healthcare Market
Every Market-Reports.com study delivers in-depth market sizing, growth forecasts, competitive intelligence, segmentation analysis, and regional insights — built from company filings, government statistics and trade data, and structured for confident strategic decision-making. Request a free report preview to see its scope, chapters and methodology before you buy.
Market Snapshot
2025 Market Size
US$ 1.2 billion
Estimated Base Value
2035 Forecast
US$ 11.2 billion
Projected Market Value
CAGR 2026–2035
25.0%
Compound Annual Growth
Largest Segment
Conversational AI Agents
Fastest Growing Segment
Electric Commercial Vehicles
Leading Region
North America
Fastest Growing Region
Latin America
Top Country
United States
By Market Share
Largest market
Key Players
Hippocratic AI
Emerging Players
Memora Health, Woebot Health
AI Agents for Healthcare Market Overview
The AI Agents for Healthcare market involves the creation and use of autonomous or semi-autonomous software entities designed to execute specific tasks, analyze data, and interact within healthcare environments. These intelligent agents utilize advanced machine learning, natural language processing, and deep learning to improve diagnostic accuracy, personalize treatment, automate administrative processes, enhance patient engagement, and support clinical decision-making. The market serves hospitals, clinics, pharmaceutical companies, biotechnology companies, diagnostic laboratories, research organizations, healthcare payers, and academic institutions, providing solutions that augment human capabilities and streamline operations.
The AI Agents for Healthcare market is estimated at $1.2 Bn in 2025 and is forecast to reach $11.2 Bn in 2035, growing at a CAGR of 25.0% (2025-2035). Demand is driven by the need for efficiency improvements due to rising healthcare costs, the shortage of healthcare professionals, and ongoing advancements in AI and machine learning. However, data privacy and security concerns, complex regulatory frameworks, high implementation costs, and integration challenges with existing legacy systems act as restraints on market expansion.
The market is segmented by Type (Conversational AI Agents, Predictive AI Agents, Diagnostic AI Agents, Autonomous AI Agents, Recommendation AI Agents, Monitoring AI Agents, Workflow Automation Agents), Application (Clinical Decision Support, Patient Engagement, Drug Discovery & Development, Medical Imaging & Diagnostics, Remote Patient Monitoring, Administrative Automation, Precision Medicine, Surgical Assistance), End-User, Technology, and Component. Geographically, the market is served across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Key companies in this market include Hippocratic AI, Suki AI, Notable Health, Viz.ai, Aidoc, Infermedica, Ada Health, K Health, Biofourmis, PathAI, Tempus, and Qure.ai. The full report provides a detailed analysis of these segments and regional dynamics.
Market Definition & Overview
The AI Agents for Healthcare Market encompasses the development, deployment, and utilization of autonomous or semi-autonomous software entities designed to perform specific tasks, analyze data, and interact within healthcare ecosystems. These intelligent agents leverage advanced machine learning, natural language processing, and deep learning technologies to enhance diagnostic accuracy, personalize treatment plans, automate administrative workflows, improve patient engagement, and support clinical decision-making across various healthcare settings. This market covers solutions that augment human capabilities, streamline operations, and ultimately improve patient outcomes by providing timely, data-driven insights and support.
Scope
- Global coverage including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
- Focus on AI agents deployed within healthcare service providers and related sectors.
- Market analysis spans from 2025 to 2035.
Inclusions
- AI-powered virtual nursing assistants and patient navigators.
- Clinical decision support AI agents for diagnosis and treatment planning.
- AI agents optimizing hospital operations, scheduling, and resource allocation.
- Predictive analytics AI agents for disease outbreak and patient risk assessment.
- AI agents supporting drug discovery, clinical trials, and personalized medicine.
- Personalized health and wellness coaching AI agents.
Exclusions
- General-purpose AI software not specifically tailored for healthcare applications.
- Stand-alone medical robotics without integrated AI agent intelligence.
- Traditional Business Intelligence (BI) tools lacking autonomous AI agent capabilities.
- Consumer electronics with health tracking features without agent intelligence.
- Purely hardware-based medical devices without AI agent components.
Market Size Forecast
Executive Summary
• The AI Agents for Healthcare market is valued at $1.2 Bn in 2025 and is forecast to reach $11.2 Bn by 2035, reflecting a robust CAGR of 25.0% as demand accelerates across every major segment and region over the ten-year outlook.
• Conversational AI Agents leads the segment breakdown by current market share, underscoring where the bulk of near-term revenue and competitive activity within this market is concentrated today.
• North America commands the largest regional share at XX.X%, while Emerging Areas is expanding the fastest at a XX.X% CAGR, signalling where future growth is shifting.
• United States remains the single largest country-level market at XX.X% of global share, anchoring overall demand within its home region throughout the forecast period.
• Rapid market entry by tech giants and specialized startups intensifies competition, necessitating unique value propositions and strategic partnerships for sustainable growth and market share consolidation.
• Evolving global regulatory frameworks, especially around data privacy and AI ethics, will dictate market access and innovation pace, favoring compliant and transparent solutions across key regions.
• Pervasive integration of generative AI and multimodal data processing within agent architectures will accelerate clinical decision support and personalized patient care across diverse healthcare settings.
• Significant venture capital influx is fueling advanced R&D in niche therapeutic areas and remote patient monitoring, creating supply chain pressure for specialized AI talent and compliant data infrastructure.
• North America and Europe lead in adoption due to robust digital infrastructure and favorable investment climates, while Asia-Pacific presents untapped growth potential despite fragmented regulatory landscapes.
• Strategic acquisitions targeting specialized AI agent capabilities and strong regional market penetration are imminent, signaling a maturation phase driven by ecosystem integration and efficiency gains.
Key Market Takeaways
Critical findings and data points from this market research study.
Current Market Value
The AI Agents for Healthcare market is currently valued at $1.2 billion in the base year, reflecting its foundational presence within the industry.
Robust Growth Outlook
This market is projected for significant expansion with an impressive Compound Annual Growth Rate (CAGR) of 25.0% through the forecast period.
Future Market Scale
By the forecast year, the AI Agents for Healthcare market is anticipated to reach a substantial valuation of $11.2 billion.
Rapid Market Expansion
The AI Agents for Healthcare market is set for rapid expansion, growing from $1.2 billion to $11.2 billion at a 25.0% CAGR by the forecast year.
North American Leadership
North America is expected to remain a leading region in the AI Agents for Healthcare market, driven by advanced technological adoption and investment.
Predictive Analytics Trend
A key trend is the increasing integration of AI agents for predictive analytics and preventative care, enhancing proactive healthcare management.
Market Dynamics
Market Trends
- Increasing adoption of LLM-powered diagnostic support tools.
- Growing focus on AI agents for administrative task automation.
- Shift towards personalized patient care through AI assistance.
- Emphasis on ethical AI and data privacy in agent development.
Growth Drivers
- Rising healthcare costs necessitate efficiency improvements.
- Shortage of healthcare professionals drives automation demand.
- Advancements in AI and machine learning capabilities fuel growth.
- Demand for improved patient outcomes and enhanced experiences.
Restraints
- Data privacy and security concerns limit adoption across healthcare.
- Complex regulatory frameworks slow the development and deployment process.
- High implementation costs and ROI uncertainty deter smaller providers.
- Integration challenges with existing legacy systems hinder seamless use.
Opportunities
- Developing AI agents for proactive remote patient monitoring.
- Creating predictive analytics tools for early disease detection.
- Integrating AI agents into existing electronic health records.
- Expanding AI agent applications in mental health support services.
Market Dynamics Framework · 2026–2035
Need Custom Data for This Market?
Get tailored segmentation, deeper competitive intelligence, or region-specific deep dives from our analyst team.
Market Segmentation
| Segment | Sub-segments |
|---|---|
| By Type | Conversational AI AgentsPredictive AI AgentsDiagnostic AI AgentsAutonomous AI AgentsRecommendation AI AgentsMonitoring AI AgentsWorkflow Automation AgentsOthers |
| By Application | Clinical Decision SupportPatient EngagementDrug Discovery & DevelopmentMedical Imaging & DiagnosticsRemote Patient MonitoringAdministrative AutomationPrecision MedicineSurgical Assistance |
| By End-User | HospitalsClinicsPharmaceutical CompaniesBiotechnology CompaniesDiagnostic LaboratoriesResearch OrganizationsHealthcare PayersAcademic Institutions |
| By Technology | Machine LearningNatural Language ProcessingDeep LearningComputer VisionGenerative AIReinforcement LearningRoboticsExpert Systems |
| By Component | Software SolutionsPlatformsServicesHardwareDevelopment ToolsIntegration ToolsTraining DataApis |
Regional Analysis
- North America leads the AI agents in healthcare market due to significant R&D investments, a robust tech ecosystem, and advanced healthcare infrastructure. Early adoption of AI technologies by major providers and favorable regulatory support further cement its dominance.
- Asia-Pacific is the fastest-growing region for AI agents in healthcare. This surge is fueled by massive patient populations, increasing healthcare expenditure, and governmental digital health initiatives, alongside a growing tech-savvy demographic keen on innovative solutions.
- In Europe, a noteworthy trend is the strong emphasis on ethical AI and data privacy regulations, particularly GDPR. This shapes the development and deployment of AI agents, ensuring patient trust and responsible innovation across diverse healthcare systems.
| North AmericaXX.X% | EuropeXX.X% | Asia PacificXX.X% | Latin AmericaXX.X% | Middle East & AfricaXX.X% |
North America
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- North America leads in AI agent adoption for healthcare, driven by significant R&D investments, advanced digital infrastructure, and a strong push for operational efficiency and personalized patient care.
Latin America
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Latin America is an emerging market with substantial growth potential, driven by efforts to modernize healthcare infrastructure, address physician shortages, and improve patient engagement through AI agents.
Europe
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Europe shows robust growth, fueled by government initiatives for digital health, an aging population, and a focus on improving healthcare accessibility and outcomes through AI-driven solutions.
Asia Pacific
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- The Asia Pacific region is experiencing rapid expansion due to increasing healthcare expenditure, a large patient base, and growing technological adoption, particularly in populous countries like China and India.
Middle East & Africa
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- This region is witnessing accelerated adoption, particularly in the Gulf Cooperation Council (GCC) countries, as governments invest heavily in digital transformation and smart city initiatives within their healthcare sectors.
Country Analysis
United States and Brazil represent the largest country-level markets, with growth across the remaining countries shaped by local regulatory, infrastructure, and demand-side factors specific to each geography.
| # | Country | Market Size | CAGR | Key Driver |
|---|---|---|---|---|
| 1 | United States | US$ XX.X Mn | XX.X% | The U.S. leads the AI agents for healthcare market due to its advanced technological infrastructure, significant R&D investments, and a complex healthcare system driving demand for efficiency and personalized care solutions. High adoption rates of digital health tools and a robust venture capital ecosystem further accelerate market growth. |
| 2 | Brazil | US$ XX.X Mn | XX.X% | Brazil is a significant market due to its large population, diverse healthcare needs, and a rapidly expanding digital health ecosystem. The demand for scalable and efficient healthcare solutions, coupled with increasing investments in AI, fuels the adoption of AI agents. |
| 3 | Germany | US$ XX.X Mn | XX.X% | Germany's robust healthcare system, strong economy, and advanced technological capabilities make it a leading market for AI agents in healthcare. Significant investment in digital health infrastructure and a focus on data privacy support the responsible integration of AI. |
| 4 | China | US$ XX.X Mn | XX.X% | China is a dominant force in the AI agents for healthcare market, driven by massive government investment, a huge patient base, and rapid technological advancements. The country's focus on AI-driven solutions for public health, diagnostics, and drug discovery positions it for exponential growth. |
| 5 | Saudi Arabia | US$ XX.X Mn | XX.X% | Saudi Arabia is heavily investing in digital transformation and healthcare modernization as part of Vision 2030, making it a rapidly emerging market for AI agents. The focus on smart cities, advanced medical facilities, and preventative care drives significant adoption of AI technologies. |
Countries Covered (27)
United States, Canada, Mexico, Brazil, Argentina, Rest of Latin America, Germany, United Kingdom, France, Sweden, Italy, Spain, Russia, Rest of Europe, China, Japan, India, South Korea, Australia, Taiwan, Singapore, Malaysia, Rest of Asia Pacific, Saudi Arabia, United Arab Emirates, South Africa, Rest of Middle East & Africa
Competitive Landscape
| # | Company | Share | Key Strategy | Key Note | Key Developments | Key Products |
|---|---|---|---|---|---|---|
| 1 | Hippocratic AI | XX.X% | Develop safe, performant large language models specifically trained for healthcare applications to augment human providers. | — | — | LLM for HealthcarePatient Safety LLMProvider Credentialing |
| 2 | Suki AI | XX.X% | Streamline clinical documentation and administrative tasks for clinicians using AI-powered voice assistant technology. | — | — | Suki AssistantSuki SpeakSuki Assistant for Epic+1 |
| 3 | Notable Health | XX.X% | Automate administrative tasks and patient workflows across the healthcare continuum using intelligent automation. | — | — | AI-powered Automation PlatformDigital IntakePatient Scheduling+1 |
| 4 | Viz.ai | XX.X% | Use AI to accelerate diagnosis and treatment for time-sensitive medical conditions, especially in stroke and cardiovascular care. | — | — | Viz ICHViz LVOViz PE+1 |
| 5 | Aidoc | XX.X% | Deploy AI solutions across hospital imaging workflows to identify critical conditions, prioritize cases, and support clinical decision-making. | — | — | Aidoc aiOSPulmonary Embolism DetectionIntracranial Hemorrhage Detection+1 |
Market Positioning Map
Market share vs. growth outlook — bubble size is market share, bubble color is relative profitability
Companies Profiled (20)
Hippocratic AI, Suki AI, Notable Health, Viz.ai, Aidoc, Infermedica, Ada Health, K Health, Biofourmis, PathAI, Tempus, Qure.ai, Enlitic, Curai Health, Buoy Health, Augmedix, DeepScribe, Glass Health, CarePredict, Akili Interactive
The global AI Agents for Healthcare market features a competitive landscape led by Hippocratic AI, Suki AI, Notable Health, Viz.ai, Aidoc, and Infermedica, among other established and emerging players. Market participants continue to compete on product innovation, pricing strategy, geographic expansion, and strategic partnerships to strengthen their position in this evolving market.
* Market share estimates based on company revenue disclosures and public sources; undisclosed figures are marked.
Company Profiles
Hippocratic AI
Suki AI
Notable Health
Viz.ai
Aidoc
Infermedica
Ada Health
K Health
Biofourmis
PathAI
Tempus
Qure.ai
Enlitic
Curai Health
Buoy Health
Augmedix
DeepScribe
Glass Health
CarePredict
Akili Interactive
* Classification reflects relative market share and maturity, derived from revenue analysis and public disclosures.
Ready to Make Data-Driven Decisions?
Purchase the full report or request a custom engagement. Get analyst support, scenario modelling, and real-time dashboard access.
Recent Market Developments
Google Health Unveils 'MediAgent' for Streamlined Clinical Workflows
Google Health announced the launch of MediAgent, an AI-powered assistant designed to reduce administrative burden and optimize clinical workflows for healthcare providers. The agent leverages advanced LLMs to summarize patient records, draft clinical notes, and manage scheduling, aiming to free up clinician time.
Mayo Clinic Partners with 'Synapse AI' for Next-Gen Diagnostic Agents
The Mayo Clinic has announced a strategic partnership with AI startup Synapse AI to develop and integrate intelligent agents capable of assisting with early disease detection and personalized treatment recommendations. This collaboration aims to enhance diagnostic accuracy and efficiency across several complex medical conditions.
'TheraBot Labs' Secures US$ XX.X Series B to Scale AI Patient Engagement Agents
TheraBot Labs, a leader in AI agents for remote patient monitoring and personalized health coaching, successfully closed a US$ XX.X Series B funding round led by a prominent venture capital firm. The capital will fuel expansion of its agent platform and accelerate development of more sophisticated patient interaction models.
IBM Watson Health Expands AI Agent Platform to Mental Health Services
IBM Watson Health announced the expansion of its AI agent capabilities to support mental health professionals, offering tools for preliminary patient screening, resource recommendation, and administrative support. This move leverages AI to address the growing demand for accessible and efficient mental healthcare solutions.
Report Data Parameters
| Parameter | Value |
|---|---|
| Base Year | 2025 |
| Forecast Year | 2035 |
| Historical Period | 2019–2025 |
| Market Size (Base Year) | $1.2 Bn |
| Market Size (Forecast) | $11.2 Bn |
| CAGR | 25.0% |
| Forecast Period | 2026–2035 |
| Geography | Global |
| Countries Covered | 27 Countries |
| Segments Covered | 5 Segments, 40 Sub-segments |
| Companies Profiled | 32 Companies |
Report Value
Why Choose This Report
Complete Market Size
Market sizing for the base year and a 10-year forecast across three scenarios.
Segment Analysis
Deep-dive segmentation by product, application, end-user, and technology verticals.
Country Analysis
Country-level market data for every country in the report scope, across all major regions.
Company Profiles
Profiles of the leading companies, with disclosed financials, strategy and market share.
Market Share
Detailed competitive market share analysis with trend mapping and benchmarking.
Competitive Intelligence
SWOT, Porter's Five Forces, and competitive positioning across market leaders.
Scenario Analysis
Three-scenario modelling (Base / Optimistic / Conservative) with CAGR decomposition.
Regulatory Review
Regulatory landscape, compliance requirements, and policy impact analysis by region.
Strategic Analysis · Management Insights · CXO Insights
Executive Strategic & Intelligence Report
A board-ready strategic deck built on the AI Agents for Healthcare Market report: eleven chapters and an appendix, from market sizing to the board decisions, delivered as a PDF with an Excel datapack. US$3,000 per market, prepared after your order.
What to expect in the Executive Report for this market
- About 400 slides, 11 chapters and an appendix. Built on this report's own numbers, so every figure matches the report and the Excel.
- Market size and forecast to 2035. By segment, sub-segment, region and country, with conservative, base and optimistic cases.
- An analysis page after every exhibit. The key insight, ten specific points and the decision it implies for leaders, challengers, entrants and investors.
- Competitive intelligence. Shares and positioning, capability benchmark, strategies, recent moves and acquisition screening.
- Customers, technology and business models. Who buys and why, AI and technology impact, pricing, channels and go-to-market by segment.
- Risks and scenarios. Risk register, four future scenarios with signposts, and early-warning indicators with thresholds.
- Opportunities and the board decisions. Opportunity scoring, strategic options, roadmap, capability gaps, decision matrix and a 90-day plan.
- PDF, Excel datapack and PowerPoint. A bookmarked PDF, the full Excel datapack and editable infographic slides for your own decks.
US$3,000 per market · bought online, prepared after your order and emailed to you
See a full example report →Only need the headline view? Market Snapshot (PDF) + Excel Datasheet · 10–20 slide PDF + Excel
A CEO-level executive summary of the market in 10–20 slides - size and forecast, growth by segment and region, the leading countries and companies, key trends and the outlook - plus the Excel datasheet. A short executive view of this market, not the full analysis - PDF and Excel, prepared and emailed to you after your order.
Trusted by strategy teams, investors & global enterprises
What Our Clients Say
Verified reviews from enterprise clients
“The depth of analysis and quality of data is unparalleled. This report directly informed our $50M market expansion strategy and helped us prioritise the right geographies.”
Sarah Chen
VP Strategy, Fortune 500 Manufacturer
“Exceptional research quality. The competitive landscape section alone saved our team months of primary research effort and gave us a clear view of the opportunity.”
Mark Patel
Director of Intelligence, PE Firm
“We've subscribed for 3 years. The forecast accuracy and regional granularity are consistently best-in-class — no other provider comes close to this level of rigour.”
Lena Hoffmann
Head of Market Intelligence, Industrial MNC
Frequently Asked Questions
Common questions about this report and our research
The AI Agents for Healthcare market is estimated at $1.2 Bn in 2025. It is forecast to reach $11.2 Bn in 2035, indicating substantial growth over the decade. This figure reflects the increasing adoption of AI solutions in various healthcare settings.
The AI Agents for Healthcare market is projected to grow at a Compound Annual Growth Rate (CAGR) of 25.0% from 2025 to 2035. This growth is driven by factors such as rising healthcare costs, the shortage of healthcare professionals, and advancements in AI technology.
The market is segmented by Type (e.g., Conversational AI Agents, Predictive AI Agents), Application (e.g., Clinical Decision Support, Patient Engagement), End-User (e.g., Hospitals, Pharmaceutical Companies), Technology (e.g., Machine Learning, Natural Language Processing), and Component (e.g., Software Solutions, Platforms). It also covers key regions globally.
Leading companies in this market include Hippocratic AI, Suki AI, Notable Health, Viz.ai, Aidoc, Infermedica, Ada Health, K Health, Biofourmis, PathAI, Tempus, and Qure.ai. These companies are developing and deploying various AI agent solutions across the healthcare sector.
The report provides a comprehensive analysis of the market, including its size, growth drivers, restraints, and opportunities. It covers detailed segmentation by Type, Application, End-User, Technology, and Component, along with regional analysis across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. It also profiles key companies.
The Single User and Enterprise licences include the full PDF report, the PowerPoint (PPT), the Excel data workbook and the interactive Online Dashboard. The Online Dashboard gives online access to the snapshot and datasheet with export features, and the Market Snapshot is an executive summary in PDF with the Excel data sheet.
Yes. Request a free report preview: its scope, every chapter and what it contains, the methodology and the headline figures. The full report is a paid product.
We accept credit/debit cards (Visa, Mastercard, Amex), bank wire transfer, and purchase orders for enterprise clients. All transactions are secured with 256-bit SSL encryption.
Buy This Report
Choose the format that fits your budget
Digital delivery — all sales are final. See our Refund Policy and Terms & Conditions.
Strategic deck for this market
Executive Strategic & Intelligence Report
About 400 board-ready slides: every exhibit with its analysis and the decision it implies. Prepared for this market after your order and emailed to you.
Need to go deeper?
Intelligence services for this market
- Competitor benchmarking →
- Market entry & expansion →
- Product & growth opportunities →
- Investment & acquisition due diligence →
What's Included
Similar Reports
AI Healthcare Command Platform Market
$918.0 Mn in 2025 · 18.5% CAGR
Clinical AI Agents Market
$1.7 Bn in 2025 · 25.6% CAGR
Healthcare Copilot Market
$1.1 Bn in 2025 · 29.4% CAGR
Healthcare Data Fabric Market
$800.0 Mn in 2025 · 21.5% CAGR
Healthcare Decision Intelligence Market
$3.9 Bn in 2025 · 18.7% CAGR
Healthcare Foundation Models Market
$664.0 Mn in 2025 · 31.5% CAGR
Healthcare Interoperability Market
$5.0 Bn in 2025 · 11.3% CAGR
Healthcare Interoperability Platform Market
$2.7 Bn in 2025 · 12.4% CAGR